glp 1 investment GLP-1 Receptor Agonist Market Size & Analysis, 2026-2033 GLP-1 Market Trends and Global

Clinical studies specifically monitoring glucose metabolism through oral glucose tolerance tests found no significant changes in glucose handling, and fasting insulin levels remained stable throughout treatment periods lasting up to 24 weeks

AHK-Cu research is more limited but more focused

Emerging evidence also suggests potential, though less established, cognitive benefits

Persistence of proliferating leukemic cells in AML/MDS patients after remission induction therapy: A new method for the detection of minimal residual disease

However, it is important to emphasize that, at present, robust clinical evidence for dual and triple agonists is derived predominantly from adult populations